316 related articles for article (PubMed ID: 18685289)
21. Current pattern of antibiotic resistance in Staphylococcus aureus clinical isolates and the emergence of vancomycin resistance.
Taj Y; Abdullah FE; Kazmi SU
J Coll Physicians Surg Pak; 2010 Nov; 20(11):728-32. PubMed ID: 21078245
[TBL] [Abstract][Full Text] [Related]
22. Vancomycin-resistant Staphylococcus aureus--New York, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(15):322-3. PubMed ID: 15103297
[TBL] [Abstract][Full Text] [Related]
23. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
24. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
Sakoulas G; Moellering RC; Eliopoulos GM
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S40-50. PubMed ID: 16323119
[TBL] [Abstract][Full Text] [Related]
25. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
Weigel LM; Donlan RM; Shin DH; Jensen B; Clark NC; McDougal LK; Zhu W; Musser KA; Thompson J; Kohlerschmidt D; Dumas N; Limberger RJ; Patel JB
Antimicrob Agents Chemother; 2007 Jan; 51(1):231-8. PubMed ID: 17074796
[TBL] [Abstract][Full Text] [Related]
26. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
Cunha BA
Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
[TBL] [Abstract][Full Text] [Related]
28. [Clinical relevance of hetero-VRSA in surgical infections].
Okii K; Takesue Y; Yokoyama T
Nihon Rinsho; 2001 Apr; 59(4):728-32. PubMed ID: 11304997
[TBL] [Abstract][Full Text] [Related]
29. Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jan; 48(51-52):1165-7. PubMed ID: 11266244
[TBL] [Abstract][Full Text] [Related]
30. Key considerations in the treatment of complicated staphylococcal infections.
Jones RN
Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
Manoharan A; Lalitha MK; Jesudason MV
Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
[TBL] [Abstract][Full Text] [Related]
33. Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals.
Borg MA; Zerafa R; Morrison D; Cuschieri P
Clin Microbiol Infect; 2005 May; 11(5):405-7. PubMed ID: 15819869
[TBL] [Abstract][Full Text] [Related]
34. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
35. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus.
Weigel LM; Clewell DB; Gill SR; Clark NC; McDougal LK; Flannagan SE; Kolonay JF; Shetty J; Killgore GE; Tenover FC
Science; 2003 Nov; 302(5650):1569-71. PubMed ID: 14645850
[TBL] [Abstract][Full Text] [Related]
36. [Is the methicillin-resistant Staphylococcus aureus heteroresistant to vancomycin in Croatia?].
Plecko V; Budimir A; Kucisec-Tepes N; Tomić Paradzik M; Zele Starcević L; Kalenić S
Acta Med Croatica; 2004; 58(4):263-8. PubMed ID: 15700681
[TBL] [Abstract][Full Text] [Related]
37. Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management.
Lewis JS; Ellis MW
Curr Opin Infect Dis; 2007 Dec; 20(6):568-73. PubMed ID: 17975405
[TBL] [Abstract][Full Text] [Related]
38. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
McDonald LC; Hageman JC
Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615
[TBL] [Abstract][Full Text] [Related]
39. Solid-phase synthesis and antibacterial activity of hydroxycinnamic acid amides and analogues against methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus.
Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A
Bioorg Med Chem Lett; 2006 Nov; 16(22):5870-3. PubMed ID: 16942872
[TBL] [Abstract][Full Text] [Related]
40. Molecular fingerprinting of meticillin-resistant Staphylococcus aureus strains isolated from patients and staff of two Iranian hospitals.
Nikbakht M; Nahaei MR; Akhi MT; Asgharzadeh M; Nikvash S
J Hosp Infect; 2008 May; 69(1):46-55. PubMed ID: 18358563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
